Pular para o conteúdo
Merck

Pular para

F4883

Fibrinogênio

35-65% protein (≥90% of protein is clottable).

Sinônimo(s):

Fator I

Faça login para ver os preços organizacionais e de contrato.

Selecione um tamanho

Alterar visualização
Para você/SKUDisponibilidadePreço

Sobre este item

Número CAS:
UNSPSC Code:
12352202
EC Number:
232-598-6
NACRES:
NA.32
MDL number:
Form:
powder
Biological source:
human plasma
Mol wt:
α-chain 63.5 kDa, β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa
Preço e disponibilidade não estão disponíveis no momento.
Assistência Técnica
Precisa de ajuda? Nossa equipe de cientistas experientes está à sua disposição.
Estamos aqui para ajudar


biological source

human plasma

Quality Segment

description

essentially plasmin(ogen) free

form

powder

quality

35-65% protein (≥90% of protein is clottable).

mol wt

α-chain 63.5 kDa, β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa

concentration

35-65% protein (biuret)

technique(s)

cell culture | mammalian: suitable

solubility

0.9% NaCl: soluble

UniProt accession no.

storage temp.

−20°C

Gene Information

General description

Fibrinogen was the first blood coagulation factor to be identified, and it is a precursor of fibrin protein. This protein is composed of two chains, each of which is composed of three chains- α, β and γ. These three subunits are coded by three genes located in the human chromosomal locus 4q23-q32, and spans 51kb.[1]

Application

Fibrinogen from human plasma has been used for-
  • fibrinogen adsorption assay performed on swCNTs (single-walled carbon nanotubes)
  • the characterization of fibrinogen structure in the presence of CNT using CD (Circular dichroism) spectroscopy and temperature scan[2]
  • the preparation of RBC suspension obtained from venous blood of antecubital vein, to assess RBC aggregability[3]
  • fibrinolysis assay performed on mouse embryonic fibroblasts (MEFs)[4]
  • the preparation of fibrinogen-labeled gold (Fgn/Au)[5]
  • the quantification of in vitro angiogenesis by human microvascular endothelial cells[6] and
  • the assessment of fibrin-induced apoptosis and differentiation-regulation in trophoblast obtained from term human placentas.[7]

Biochem/physiol Actions

O fibrinogênio é uma proteína de fase aguda que faz parte da cascata de coagulação de proteínas. O resultado final da cascata é a produção de trombina, que converte fibrinogênio em fibrina. A trombina proteolisa rapidamente o fibrinogênio, liberando o fibrinopeptídeo A. A perda desse pequeno peptídeo não é suficiente para tornar a molécula de fibrina resultante insolúvel, mas tende a formar complexos com as moléculas adjacentes de fibrina e fibrinogênio. Em seguida, a trombina cliva da fibrina um segundo peptídeo, o fibrinopeptídeo B, e, então, os monômeros de fibrina formados se polimerizam espontaneamente para formar um gel insolúvel. A fibrina polimerizada é mantida íntegra por forças não covalentes e eletrostáticas e estabilizada pela enzima de transamidação, fator XIIIa, que é produzida pela ação da trombina sobre o fator XIII. Os agregados insolúveis de fibrina (coágulos) e as plaquetas agregadas bloqueiam, então, o vaso sanguíneo danificado e impedem sangramento adicional. A quantidade de fibrinogênio no plasma pode funcionar como um indicador não específico da presença ou ausência de um processo inflamatório no organismo. O fibrinogênio originário de qualquer mamífero será clivado por uma trombina originária de qualquer mamífero.
Proteína de fase aguda que faz parte da cascata de coagulação de proteínas.
Fibrinogen is an acute-phase inflammatory protein, which plays an essential role in blood clotting. Coronary heart disease is linked to the plasma levels of fibrinogen in Chinese population, and might have potential as a marker and risk factor for the same.[1] A -455 allele of fibrinogen β (FGB) chain is linked with poor survival in Caucasian women with Finnish stroke.[8] Ischemic stroke preceded by hyperfibrinogenemia has poor outcome, which is independent of the baseline fibrinogen concentration.[9]

Features and Benefits

Source material has tested negative for HIV and HBsAg.

Physical form

Lyophilized powder containing sodium citrate and sodium chloride.

Analysis Note

Protein determined by biuret

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Comparar Itens Semelhantes

Ver Comparação Total

Mostrar diferenças

1 of 1

Este Item
F3879F5386F6755
Fibrinogênio 35-65% protein (≥90% of protein is clottable).

Sigma-Aldrich

F4883

Fibrinogênio

Fibrinogênio 50-70% protein (≥80% of protein is clottable)

Sigma-Aldrich

F3879

Fibrinogênio

biological source

human plasma

biological source

human plasma

biological source

human plasma

biological source

rat plasma

technique(s)

cell culture | mammalian: suitable

technique(s)

ELISA: suitable

technique(s)

indirect ELISA: suitable

technique(s)

cell culture | mammalian: suitable, immunoblotting: suitable

concentration

35-65% protein (biuret)

concentration

50-70% protein (biuret)

concentration

-

concentration

60-80% (biuret)

form

powder

form

powder

form

powder

form

powder

mol wt

α-chain 63.5 kDa, γ chain 47 kDa (about 4% carbohydrate content), β-chain 56 kDa, soluble dimer 340 kDa

mol wt

α-chain 63.5 kDa, β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa

mol wt

-

mol wt

α-chain 63.5 kDa, β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa

solubility

0.9% NaCl: soluble

solubility

0.9% NaCl: soluble 10 mg/mL

solubility

-

solubility

-


Still not finding the right product?

Explore all of our products under Fibrinogênio


Classe de armazenamento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos



Questions

1–3 of 3 Questions  
  1. storage and thawing Is it possible to store at -20 freezer and repeated freezing and thawing

    1 answer
    1. This product has not been tested for freeze-thaw stability. However, in powder form, repeatedly removing this product from a freezer for the purpose of preparing fresh solutions, is not expected to be detrimental to the protein. Prepared solutions may be stored up to 1 week at 2 - 8 °C. It is not recommended to freeze stock solutions, as the freeze-thaw process may lead to protein degradation.
      Please see the link below to review additional information available in the product datasheet:
      https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/299/301/f4883pis.pdf

      Helpful?

  2. F4883-500MG contains Sodium Citrate and Sodium Chlorure. Is it possible to have their concentration ? What is the volume of sodium chloride we have to put in the bottle please?

    1 answer
    1. This material is lyophilized from a solution of 75 mM NaCl (4.39 mg/mL), 10 mM Na Citrate (2.94 mg/mL). It can be solubilized in 0.85% (w/v) sodium chloride to 2 mg/ml, by layering the protein on top of the saline solution and placing it in a 37°C water bath for 4-6 hours, with gentle agitation.

      Helpful?

  3. Hello. For your F4883-500MG Fibrinogen product, is there 500mg of pure fibrinogen in the vial? Or is there 500 mg of reagent - of which a fraction is clottable Fibrinogen? Do you have preparation instructions for this reagent?

    1 answer
    1. F4883-500MG contains 500 mg of solid. Fibrinogen can be solubilized in 0.85% (w/v) sodium chloride (2 mg/ml) by layering the protein on top of the saline solution and placing it in a 37 °C water bath for 4-6 hours with gentle agitation.

      Helpful?

Reviews

No rating value

Active Filters